These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 25049241)
21. The broad amine scope of pantothenate synthetase enables the synthesis of pharmaceutically relevant amides. Abidin MZ; Saravanan T; Strauss E; Poelarends GJ Org Biomol Chem; 2021 May; 19(20):4515-4519. PubMed ID: 33913984 [TBL] [Abstract][Full Text] [Related]
22. Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis. Leesombun A; Iijima M; Umeda K; Kondoh D; Pagmadulam B; Abdou AM; Suzuki Y; Ohba SI; Isshiki K; Kimura T; Kubota Y; Sawa R; Nihei CI; Nishikawa Y J Infect Dis; 2020 Feb; 221(5):766-774. PubMed ID: 31573038 [TBL] [Abstract][Full Text] [Related]
23. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. Aspinall TV; Joynson DH; Guy E; Hyde JE; Sims PF J Infect Dis; 2002 Jun; 185(11):1637-43. PubMed ID: 12023770 [TBL] [Abstract][Full Text] [Related]
24. Antiplasmodial Mode of Action of Pantothenamides: Pantothenate Kinase Serves as a Metabolic Activator Not as a Target. de Villiers M; Spry C; Macuamule CJ; Barnard L; Wells G; Saliba KJ; Strauss E ACS Infect Dis; 2017 Jul; 3(7):527-541. PubMed ID: 28437604 [TBL] [Abstract][Full Text] [Related]
25. Active site residues in Mycobacterium tuberculosis pantothenate synthetase required in the formation and stabilization of the adenylate intermediate. Zheng R; Dam TK; Brewer CF; Blanchard JS Biochemistry; 2004 Jun; 43(22):7171-8. PubMed ID: 15170354 [TBL] [Abstract][Full Text] [Related]
26. Targeting Evans JC; Murugesan D; Post JM; Mendes V; Wang Z; Nahiyaan N; Lynch SL; Thompson S; Green SR; Ray PC; Hess J; Spry C; Coyne AG; Abell C; Boshoff HIM; Wyatt PG; Rhee KY; Blundell TL; Barry CE; Mizrahi V ACS Infect Dis; 2021 Jun; 7(6):1666-1679. PubMed ID: 33939919 [TBL] [Abstract][Full Text] [Related]
28. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice. Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617 [No Abstract] [Full Text] [Related]
29. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition. Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210 [TBL] [Abstract][Full Text] [Related]
30. A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites. Spry C; Chai CL; Kirk K; Saliba KJ Antimicrob Agents Chemother; 2005 Nov; 49(11):4649-57. PubMed ID: 16251308 [TBL] [Abstract][Full Text] [Related]
31. Knocking down of the DHFR-TS gene in Toxoplasma gondii using siRNA and assessing the subsequences on toxoplasmosis in mice. Azimi-Resketi M; Eskandarian A; Ganjalikhani-Hakemi M; Zohrabi T Acta Trop; 2020 Jul; 207():105488. PubMed ID: 32277926 [TBL] [Abstract][Full Text] [Related]
32. D-Pantothenate synthesis in Corynebacterium glutamicum and use of panBC and genes encoding L-valine synthesis for D-pantothenate overproduction. Sahm H; Eggeling L Appl Environ Microbiol; 1999 May; 65(5):1973-9. PubMed ID: 10223988 [TBL] [Abstract][Full Text] [Related]
34. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728 [TBL] [Abstract][Full Text] [Related]
35. The final step of pantothenate biosynthesis in higher plants: cloning and characterization of pantothenate synthetase from Lotus japonicus and Oryza sativum (rice). Genschel U; Powell CA; Abell C; Smith AG Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):669-78. PubMed ID: 10417331 [TBL] [Abstract][Full Text] [Related]
36. The Coenzyme A Level Modulator Hopantenate (HoPan) Inhibits Phosphopantotenoylcysteine Synthetase Activity. Mostert KJ; Sharma N; van der Zwaag M; Staats R; Koekemoer L; Anand R; Sibon OCM; Strauss E ACS Chem Biol; 2021 Nov; 16(11):2401-2414. PubMed ID: 34582681 [TBL] [Abstract][Full Text] [Related]
37. Screening for small molecule inhibitors of Toxoplasma gondii. Kortagere S Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671 [TBL] [Abstract][Full Text] [Related]
38. Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum. Saliba KJ; Horner HA; Kirk K J Biol Chem; 1998 Apr; 273(17):10190-5. PubMed ID: 9553068 [TBL] [Abstract][Full Text] [Related]
39. A highly active pantothenate synthetase from Corynebacterium glutamicum enables the production of D-pantothenic acid with high productivity. Tigu F; Zhang J; Liu G; Cai Z; Li Y Appl Microbiol Biotechnol; 2018 Jul; 102(14):6039-6046. PubMed ID: 29737393 [TBL] [Abstract][Full Text] [Related]
40. Isolation and molecular characterization of the bifunctional hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase gene from Toxoplasma gondii. Pashley TV; Volpe F; Pudney M; Hyde JE; Sims PF; Delves CJ Mol Biochem Parasitol; 1997 May; 86(1):37-47. PubMed ID: 9178266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]